441 related articles for article (PubMed ID: 17016160)
1. Acetylcholinesterase inhibition in patients with orthostatic intolerance.
Singer W; Opfer-Gehrking TL; Nickander KK; Hines SM; Low PA
J Clin Neurophysiol; 2006 Oct; 23(5):476-81. PubMed ID: 17016160
[TBL] [Abstract][Full Text] [Related]
2. Pyridostigmine treatment trial in neurogenic orthostatic hypotension.
Singer W; Sandroni P; Opfer-Gehrking TL; Suarez GA; Klein CM; Hines S; O'Brien PC; Slezak J; Low PA
Arch Neurol; 2006 Apr; 63(4):513-8. PubMed ID: 16476804
[TBL] [Abstract][Full Text] [Related]
3. Pyridostigmine in the treatment of orthostatic intolerance.
Gales BJ; Gales MA
Ann Pharmacother; 2007 Feb; 41(2):314-8. PubMed ID: 17284509
[TBL] [Abstract][Full Text] [Related]
4. [Pyridostigmine in the treatment of primary orthostatic hypotension].
Monge Argiles JA; Leiva Santana C
Neurologia; 2007 May; 22(4):260-2. PubMed ID: 17492522
[TBL] [Abstract][Full Text] [Related]
5. Hemodynamic, autonomic and neurohormonal behaviour of familial amyloidotic polyneuropathy and neurally mediated syncope patients during supine and orthostatic stress.
Freitas J; Santos R; Azevedo E; Carvalho M; Boomsma F; Meiracker A; Falcão de Freitas A; Abreu-Lima C
Int J Cardiol; 2007 Mar; 116(2):242-8. PubMed ID: 16843544
[TBL] [Abstract][Full Text] [Related]
6. Acetylcholinesterase inhibition: a novel approach in the treatment of neurogenic orthostatic hypotension.
Singer W; Opfer-Gehrking TL; McPhee BR; Hilz MJ; Bharucha AE; Low PA
J Neurol Neurosurg Psychiatry; 2003 Sep; 74(9):1294-8. PubMed ID: 12933939
[TBL] [Abstract][Full Text] [Related]
7. Comparative efficacy of yohimbine against pyridostigmine for the treatment of orthostatic hypotension in autonomic failure.
Shibao C; Okamoto LE; Gamboa A; Yu C; Diedrich A; Raj SR; Robertson D; Biaggioni I
Hypertension; 2010 Nov; 56(5):847-51. PubMed ID: 20837887
[TBL] [Abstract][Full Text] [Related]
8. Sympathetic vasoconstriction and orthostatic intolerance after simulated microgravity.
Kamiya A; Michikami D; Fu Q; Iwase S; Mano T
J Gravit Physiol; 1999 Jul; 6(1):P101-2. PubMed ID: 11542976
[TBL] [Abstract][Full Text] [Related]
9. Synergistic Pressor Effect of Atomoxetine and Pyridostigmine in Patients With Neurogenic Orthostatic Hypotension.
Okamoto LE; Shibao CA; Gamboa A; Diedrich A; Raj SR; Black BK; Robertson D; Biaggioni I
Hypertension; 2019 Jan; 73(1):235-241. PubMed ID: 30571543
[TBL] [Abstract][Full Text] [Related]
10. Diagnostic management of orthostatic intolerance in the workplace.
Winker R; Barth A; Dorner W; Mayr O; Pilger A; Ivancsits S; Ponocny I; Heider A; Wolf C; Rüdiger HW
Int Arch Occup Environ Health; 2003 Mar; 76(2):143-50. PubMed ID: 12733087
[TBL] [Abstract][Full Text] [Related]
11. Baroreflex control of heart rate during heating in subjects with low orthostatic tolerance.
Yamazaki F; Kawahara C; Soga I; Yamada S; Hamasaki K
Aviat Space Environ Med; 2003 Dec; 74(12):1237-42. PubMed ID: 14692465
[TBL] [Abstract][Full Text] [Related]
12. Pyridostigmine in the treatment of postural orthostatic tachycardia: a single-center experience.
Kanjwal K; Karabin B; Sheikh M; Elmer L; Kanjwal Y; Saeed B; Grubb BP
Pacing Clin Electrophysiol; 2011 Jun; 34(6):750-5. PubMed ID: 21410722
[TBL] [Abstract][Full Text] [Related]
13. [Effects of octreotide on experimental orthostatic neurogenic hypotension].
Verwaerde P; Bordet R; Portolan G; Tran MA; Marques MA; Montastruc JL; Sénard JM
Arch Mal Coeur Vaiss; 1996 Aug; 89(8):1097-1101. PubMed ID: 8949386
[TBL] [Abstract][Full Text] [Related]
14. Residual wires and autonomic failure treatment.
Jordan J
Clin Auton Res; 2006 Jun; 16(3):200-1. PubMed ID: 16871652
[No Abstract] [Full Text] [Related]
15. Distinct neurohumoral biomarker profiles in children with hemodynamically defined orthostatic intolerance may predict treatment options.
Wagoner AL; Shaltout HA; Fortunato JE; Diz DI
Am J Physiol Heart Circ Physiol; 2016 Feb; 310(3):H416-25. PubMed ID: 26608337
[TBL] [Abstract][Full Text] [Related]
16. Pyridostigmine bromide versus fludrocortisone in the treatment of orthostatic hypotension in Parkinson's disease - a randomized controlled trial.
Schreglmann SR; Büchele F; Sommerauer M; Epprecht L; Kägi G; Hägele-Link S; Götze O; Zimmerli L; Waldvogel D; Baumann CR
Eur J Neurol; 2017 Apr; 24(4):545-551. PubMed ID: 28224720
[TBL] [Abstract][Full Text] [Related]
17. Effects of orthostatic self-training on head-up tilt testing and autonomic balance in patients with neurocardiogenic syncope.
Abe H; Kohshi K; Nakashima Y
J Cardiovasc Pharmacol; 2003 Jan; 41 Suppl 1():S73-6. PubMed ID: 12688401
[TBL] [Abstract][Full Text] [Related]
18. Orthostatic responses to anticholinesterase inhibition in spinal cord injury.
Wecht JM; Cirnigliaro CM; Azarelo F; Bauman WA; Kirshblum SC
Clin Auton Res; 2015 Jun; 25(3):179-87. PubMed ID: 25916633
[TBL] [Abstract][Full Text] [Related]
19. Impaired cardiovascular autonomic control in newly and long-term-treated patients with Parkinson's disease: involvement of L-dopa therapy.
Bouhaddi M; Vuillier F; Fortrat JO; Cappelle S; Henriet MT; Rumbach L; Regnard J
Auton Neurosci; 2004 Nov; 116(1-2):30-8. PubMed ID: 15556835
[TBL] [Abstract][Full Text] [Related]
20. Orthostatic intolerance: emerging genetic and environmental etiologies.
Robertson D; Biaggioni I; Ertl AC; Robertson RM; Diedrich A; Blakely RD; Flattem N; Shannon JR
J Gravit Physiol; 1999 Jul; 6(1):P51-4. PubMed ID: 11543025
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
